Skip to content
BioROSA Technologies logo — Enabling early detection of autism and related disorders

BioROSA Technologies

Enabling early detection of autism and related disorders

Founded 2018 United States Boston, United States 4 employees Debt Financing Total: $745.00K Biotechnology, Health Care +2

General Information

Company Name BioROSA Technologies
Founded Year 2018
Location United States Boston, United States
Employees 4
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with BioROSA Technologies. To contact BioROSA Technologies, visit biorosa.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BioROSA Technologies compare?

A PDF of BioROSA Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BioROSA Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BioROSA Technologies

BioROSA Technologies is a biotechnology, health care, and robotics company based in the United States, founded in 2018. The company's mission revolves around enabling early detection of autism and related disorders, with the slogan "Enabling early detection of autism and related disorders." BioROSA Technologies aims to revolutionize the diagnosis of Autism Spectrum Disorder (ASD) by making it rapid and simple. The company recently secured a noteworthy $745.00K debt financing investment on 22 November 2022. This injection of funds is a testament to their potential in the industry, driving their efforts to make a significant impact in the field of autism detection and beyond. With their innovative approach and the support garnered from their recent investment, BioROSA Technologies exhibits promise in addressing a crucial need in the healthcare landscape.

Business keywords: autism, early detection, disorders, diagnosis, rapid, simple, BioROSA Technologies, innovation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $745.00K -
22 Nov 2022
Convertible Note Undisclosed 2
SOSV, indiebio
18 Nov 2022
Venture Round Undisclosed 1
Autism Impact Fund
10 Nov 2021
Seed Round Undisclosed 1
Bioverge Ventures
15 Jul 2021
Convertible Note Undisclosed 2
SOSV, Zoic Capital
02 Jul 2020
Convertible Note Undisclosed 2
SOSV, indiebio
02 Jul 2019
Seed Round Undisclosed 2
SOSV, indiebio
14 Jun 2018

BioROSA Technologies Alternatives & Competitors

View All Alternatives
BioROSA Technologies vs

Pioneering early diagnosis and intervention for autism and other complex diseases through innovative...

Series C
51-200 employees
Biotechnology, Health Care
BioROSA Technologies vs

WINDOW INTO THE BRAIN™ - Empowering early detection and improved care for brain disorders through in...

Series A
Biotechnology, Health Care
BioROSA Technologies vs

Focused on early detection and non-invasive treatment, we aim to be the comprehensive provider for p...

Series C
Health Care, Robotics

FAQ About BioROSA Technologies

Enabling early detection of autism and related disorders
BioROSA Technologies was founded in 2018.
BioROSA Technologies is headquartered in Boston, United States.
BioROSA Technologies operates in Biotechnology, Health Care, Life Sciences and Robotics. Its work centres on autism, early detection, disorders and diagnosis.
BioROSA Technologies has approximately 4 employees.
BioROSA Technologies has completed 7 funding rounds, raising a total of $745.00K. The latest funding stage is Debt Financing.
Top alternatives and competitors to BioROSA Technologies include Lineagen, MSDx, Langhe Medical, Cytovale, Onalabs Inno-Hub. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioROSA Technologies and Lineagen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BioROSA Technologies, https://bouncewatch.com/company/biorosa-technologies, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout